L‐asparaginase doses number as a prognostic factor in childhood acute lymphoblastic leukemia: A survival analysis study

BACKGROUND: The survival of children with acute lymphoblastic leukemia (ALL) has improved due to changes in the treatment and the disease diagnosis. A significant advance was the incorporation of asparaginase. However, hypersensitivity reactions are a common cause of early discontinuation of this dr...

Descripción completa

Detalles Bibliográficos
Autores principales: dos Santos, Amanda Cabral, dos Santos, Julia Maria Bispo, da Costa Lima, Elisangela, Land, Marcelo Gerardin Poirot
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351670/
https://www.ncbi.nlm.nih.gov/pubmed/34431241
http://dx.doi.org/10.1002/cnr2.1533

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9351670/
https://www.ncbi.nlm.nih.gov/pubmed/34431241
http://dx.doi.org/10.1002/cnr2.1533

Ejemplares similares